FDA 483 - Organics Corporation of America DBA Ambix Laboratories - May 07, 2012
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Organics Corporation of America DBA Ambix Laboratories in Totowa, NJ, revealed significant deficiencies in the manufacturing of dietary supplements. The firm failed to verify finished product specifications, adequately test incoming components, and maintain proper cleaning and sanitizing documentation for equipment. Additionally, components were not stored under appropriate environmental conditions, indicating a lack of control over product quality and potential for adulteration.
- Inspection Date
- May 7, 2012
- Product Type
- Other
ID · 34d96b95-79ec-4298-8cbf-e984fbd158cd